The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,050.00
Bid: 12,038.00
Ask: 12,040.00
Change: -106.00 (-0.87%)
Spread: 2.00 (0.017%)
Open: 12,092.00
High: 12,178.00
Low: 12,010.00
Prev. Close: 12,156.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

London open: Stocks buoyed by China factory PMI, US-China trade news

Mon, 01st Apr 2019 08:35

(Sharecast News) - Stocks are kicking-off the new quarter on the front foot, helped by stronger-than-expected economic data out of the People's Republic of China and further positive news on the state of US-China trade talks.But ahead of another round of indicative votes in the British Parliament, later on Monday, on possible alternatives to the Prime Minister's proposed withdrawal agreement, a warning from Easyjet reminded investors of the toll that uncertainty surrounding the UK's exit from the European Union was taking on companies, as did another weak reading on German factory activity.In a statement, Easyet said: "Macroeconomic uncertainty and many unanswered questions surrounding Brexit are together driving weaker customer demand."As of 0835 GMT the FTSE 100 was ahead by 0.82% to 7,338.90. In parallel, front month Brent crude oil futures were adding 1.3% to $68.48 a barrel on the ICE and the pound was rising 0.08% to 1.1629.Also out of China, ahead of vice premier Liu He's trip to Washington this week for another round of trade negotiations, Beijing said it would extend a freeze on retaliatory tariffs on US car exports and add the opioid fentanyl to a list of controlled substances.Against that backdrop, all eyes were on a round of global manufacturing data due out at the start of the week, as investors tried to gauge whether a bottom was about to fall into place for the sector, which in turn might signal greater strength in stockmarkets around the world - or not.On that note, readings on Chinese factory sector activity in March released overnight printed ahead of forecasts, although economists appeared somewhat unconvinced by the figures, telling clients that at least some further weakness might yet be on the cards.Survey compiler Caixin's Chinese manufacturing Purchasing Managers' Index for March printed at 50.8, versus a reading of just 49.5 for the month before and economists' forecasts for a reading of 50.0.Some market commentary was also highlighting the possibility that seasonal factors, tied to the timing of the Lunar New Year in 2019, might lie behind that strength.Commenting on the Caixin PMI, Julian Evans-Pritchard at Capital Economics said: "there is now a decent chance that growth in China may bottom out slightly earlier than we had previously anticipated. That said, we still think growth could weaken again in the near-term. The recent trajectory of credit growth still points to a slowdown in the coming months."Going the other way, IHS Markit's factory sector PMIs for Germany and France were both revised lower.For later in the session, investors will be focusing on two key economic reports out of the States, those on retail sales covering the month of February at 1330 GMT, followed by the ISM's manufacturing sector index for March at 1500 GMT.Also due out was a manufacturing sector PMI for the month of March in the UK at 0930 GMT.In broker note action, analysts at Berenberg revised their recommendation for shares of Royal Mail from 'sell' to 'hold'.Fasten your seatbelts: Easyjet eyes potential turbulence aheadEasyJet said uncertainty over Brexit and the economy made the budget airline more cautious on its outlook as the airline reported first-half trading in line with guidance. The FTSE 100 carrier expects to post a headline pre-tax loss of £275m for the six months to the end of March as revenue rises 7.3% to about £2.34bn. Airlines traditionally report losses for the winter months. Revenue per seat will be about 7.4% lower, which easyJet said was in line with guidance issued in January. Costs per seat rose about 1.4% as crew costs increased.Ferrexpo announced a further delay to its annual results to give more time for an independent review of the company's donations to the charity Blooming Land. The FTSE 250 miner said it would publish its 2018 results on or before 25 April. It had previously delayed publication from 20 March to 3 April. An independent committee is examining the company's donations to Blooming Land, a Ukrainian charity set up to coordinate Ferrexpo's corporate and social responsibility programme.Rio Tinto said iron ore shipments from Pilbara in Australia would be at the low end of guidance after a cyclone damaged a port used to transport the commodity. Production from Pilbara will be about 14m tonnes lower than expected in 2019, the FTSE 100 miner said. As a result shipments of iron ore from the region will be at the low end of its guidance of 338m to 350m tonnes.AstraZeneca announced on Monday that the US Food and Drug Administration (FDA) has granted 'Breakthrough Therapy Designation' (BTD) for the MEK 1/2 inhibitor and potential new medicine selumetinib, which it is developing alongside its partner Merck. The FTSE 100 pharmaceuticals giant said the designation was for the treatment of paediatric patients aged three years and older with neurofibromatosis type 1 symptomatic or progressive, inoperable plexiform neurofibromas, which it described as a rare, incurable genetic condition.Sports Direct has prepared a template letter for other shareholders in Debenhams to use as part of boss Mike Ashley's push to install himself as chief executive of the troubled department store group. Sports Direct said on Monday that it had been contacted by "a number" of other concerned shareholders in Debenhams, concerned they will see the value of their shares wiped out by Debenhams financial restructuring plans and "expressing their support" for Ashley's appointment as CEO there.Market MoversFTSE 100 (UKX) 7,339.01 0.82%FTSE 250 (MCX) 19,234.48 0.61%techMARK (TASX) 3,540.75 0.95%FTSE 100 - RisersAshtead Group (AHT) 1,916.50p 3.45%WPP (WPP) 837.20p 3.26%Melrose Industries (MRO) 188.15p 2.73%Glencore (GLEN) 325.75p 2.45%BHP Group (BHP) 1,892.00p 2.35%Johnson Matthey (JMAT) 3,210.00p 2.16%Rio Tinto (RIO) 4,554.50p 2.10%Evraz (EVR) 633.20p 2.06%Smith (DS) (SMDS) 342.80p 2.05%AstraZeneca (AZN) 6,261.00p 2.05%FTSE 100 - FallerseasyJet (EZJ) 1,036.50p -7.25%International Consolidated Airlines Group SA (CDI) (IAG) 504.04p -1.55%TUI AG Reg Shs (DI) (TUI) 727.20p -1.14%SSE (SSE) 1,177.00p -0.84%Severn Trent (SVT) 1,961.50p -0.73%Fresnillo (FRES) 865.80p -0.57%Kingfisher (KGF) 233.70p -0.47%Centrica (CNA) 113.78p -0.37%Associated British Foods (ABF) 2,431.00p -0.33%Admiral Group (ADM) 2,165.00p -0.23%FTSE 250 - RisersContour Global (GLO) 179.80p 4.17%Ferrexpo (FXPO) 257.35p 3.94%Babcock International Group (BAB) 509.80p 3.30%Amigo Holdings (AMGO) 186.00p 3.20%John Laing Group (JLG) 391.80p 3.11%Royal Mail (RMG) 245.68p 3.10%Premier Oil (PMO) 96.67p 2.90%Weir Group (WEIR) 1,601.00p 2.76%Ted Baker (TED) 1,600.00p 2.70%Investec (INVP) 454.10p 2.67%FTSE 250 - FallersStobart Group Ltd. (STOB) 146.19p -3.82%Wizz Air Holdings (WIZZ) 2,936.98p -2.43%TBC Bank Group (TBCG) 1,522.00p -1.42%Telecom Plus (TEP) 1,500.00p -1.32%Just Group (JUST) 60.50p -1.14%Kier Group (KIE) 359.40p -1.05%HICL Infrastructure (HICL) 154.50p -0.90%Inmarsat (ISAT) 550.20p -0.86%Civitas Social Housing (CSH) 95.24p -0.79%Savills (SVS) 897.50p -0.77%
More News
11 Apr 2024 17:13

FTSE 100 edges lower as financials drag

Lok'nStore surges to all-time high after buyout by Shurgard

*

Read more
11 Apr 2024 17:07

Banks weigh down Europe's STOXX 600 after ECB signals rate cuts

Outlook hike sends Ambu shares up

*

Read more
11 Apr 2024 15:56

London close: Stocks finish lower as ECB stands pat

(Sharecast News) - London's stock markets finished in negative territory on Thursday, as investors reacted to the European Central Bank's latest policy announcement and a producer price index release in the United States.

Read more
11 Apr 2024 11:50

LONDON MARKET MIDDAY: Europe takes hit on nerves ahead of ECB decision

(Alliance News) - European equities sunk lower at midday on Thursday, with sentiment hurt by hotter-than-expected inflation from the US crushing hopes of interest rate cuts.

Read more
11 Apr 2024 08:56

TOP NEWS: Astra plans 7% dividend hike for 2024 after no rise in 2023

(Alliance News) - AstraZeneca PLC said it intends to raise its annualised dividend for 2024, citing confidence in its business performance and cash generation.

Read more
11 Apr 2024 08:54

LONDON MARKET OPEN: European markets mixed ahead of ECB decision

(Alliance News) - European equities lacked direction early Thursday morning, ahead of an interest rate decision from the European Central Bank this afternoon.

Read more
11 Apr 2024 07:49

LONDON BRIEFING: Astra promises dividend hike; Darktrace ups guidance

(Alliance News) - Stocks in London are called to open slightly higher on Thursday, as investors eye the latest interest rate decision from the European Central Bank, a day after a hotter-than-expected US inflation reading.

Read more
11 Apr 2024 07:20

AstraZeneca to hike 2024 dividend by 7%

(Sharecast News) - Biopharma giant AstraZeneca has announced that it will increase its annual dividend by 7%, which the board said demonstrates its confidence in the company's performance and cash generation.

Read more
8 Apr 2024 08:36

TOP NEWS: AstraZeneca hails neurological data for Ultomiris, Soliris

(Alliance News) - AstraZeneca PLC on Monday said long-term data in generalised myasthenia gravis will underscore the "vital role" of its Ultomiris and Soliris antibodies in the treatment landscape.

Read more
8 Apr 2024 07:43

LONDON BRIEFING: Astra hails neurology data; CVS flags cyberattack

(Alliance News) - London's FTSE 100 is called to open a touch higher on Monday, ahead of an interest rate decision in the eurozone and a US inflation reading later in the week.

Read more
8 Apr 2024 07:02

AstraZeneca's Enhurtu cancer gets US green light for adult patients

(Sharecast News) - AstraZeneca and Daiichi Sankyo's Enhertu cancer drug has been approved in the US for adult patients with unresectable or metastatic solid tumours who have received prior systemic treatment and have no satisfactory alternative options.

Read more
8 Apr 2024 06:53

TOP NEWS: AstraZeneca's, Daiichi's Enhertu receives US FDA approval

(Alliance News) - AstraZeneca PLC and Daiichi Sankyo Co Ltd on Saturday announced that the US Food & Drug Administration has approved their cancer drug conjugate for patients with metastatic HER2-positive solid tumours.

Read more
5 Apr 2024 09:42

AstraZeneca makes "breakthrough" in treating small cell lung cancer

(Alliance News) - AstraZeneca PLC on Friday reported positive results relating to its Imfinzi cancer treatment in phase III trials.

Read more
5 Apr 2024 07:50

LONDON BRIEFING: Shell to book USD600 million first-quarter write-off

(Alliance News) - London's FTSE 100 is called to open lower on Friday, with hawkish remarks from Federal Reserve policymakers and fears of ratcheting Middle East tensions giving investors little to cheer about ahead of the latest US jobs data.

Read more
5 Apr 2024 07:23

AstraZeneca announces positive lung cancer treatment trial results

(Sharecast News) - AstraZeneca announced positive high-level results from a phase three trial demonstrating significant advancements in the treatment of limited-stage small cell lung cancer (LS-SCLC) on Friday.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.